SCHEMBL21149244

SCHEMBL21149244

c1ccc2c(c1)ccc1cc(-c3nc(-c4ccc(-c5cccc6sc7ccccc7c56)cc4)nc(-c4ccc(-c5cccc6sc7ccccc7c56)cc4)n3)ccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F9 P00740 1/20 0.36
ALDH1A1 P00352 4/20 0.36
HSD17B10 Q99714 3/20 0.36
HPGD P15428 3/20 0.36
HIF1A Q16665 2/20 0.36
TSHR P16473 2/20 0.36
MAPK1 P28482 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
CYP1A2 P05177 2/20 0.36
ERBB2 P04626 1/20 0.36
FYN P06241 1/20 0.36
MAOA P21397 1/20 0.36
ACHE P22303 1/20 0.36
AHR P35869 1/20 0.36
CASP1 P29466 1/20 0.36
NQO1 P15559 1/20 0.35
NQO2 P16083 1/20 0.35
CYP1B1 Q16678 2/20 0.34
ALOX5 P09917 1/20 0.34
S1PR5 Q9H228 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21148726 0.94 F9 (0.36) F9ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL24523536 0.93 F9 (0.36) F9ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL24523445 0.93 F9 (0.36) F9ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL24523651 0.93 F9 (0.36) F9ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL26047246 0.93 F9 (0.36) F9ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL24266399 0.92 S1PR5 (0.40) ALDH1A1HSD17B10HPGDCYP1A2ALOX5
SCHEMBL21149245 0.92 S1PR5 (0.40) ALDH1A1HSD17B10HPGDCYP1A2ALOX5
SCHEMBL25621659 0.91 F9 (0.37) F9ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL24473296 0.91 F9 (0.37) F9ALDH1A1HSD17B10HPGDHIF1A
SCHEMBL21148578 0.91 S1PR5 (0.40) F9ALDH1A1HSD17B10HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 F9 479/4885ALDH1A1 191/4885HSD17B10 1380/4885
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 F9 479/4885ALDH1A1 191/4885HSD17B10 1380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.